Cardiometabolic Medical Science Liaison (Mid-Atlantic)

Role: Field-based cardiometabolic Medical Science Liaison (MSL) supporting Arrowhead’s RNAi therapies targeting hypertriglyceridemia, familial chylomicronemia syndrome, and hypercholesterolemia. Objectives: foster scientific engagement with healthcare professionals, support clinical trials, and communicate clinical data to advance therapeutic understanding. Responsibilities: build relationships with cardiologists/endocrinologists, educate on RNAi technology and disease areas, synthesize insights for internal teams, represent at scientific congresses, respond to inquiries, support speaker and educational initiatives, monitor scientific landscape, and develop territory plans. Requirements: PhD, PharmD, MD, or DO; 5+ years as an MSL in cardiometabolic areas; biotech/pharma Medical Affairs experience; strong communication, scientific, and strategic skills; understanding of healthcare systems, clinical research, and research interpretation; ability to travel. HighValue: cardiometabolic therapeutic area, RNA interference technology, clinical stage and launch support, scientific congress representation, cross-functional collaboration. WorkSetup: field-based within designated territory.